Lawrence S. Carson - 10 Nov 2023 Form 4 Insider Report for REINSURANCE GROUP OF AMERICA INC (RGA)

Role
EVP, GFS
Signature
/s/ William L. Hutton, by Power of Attorney
Issuer symbol
RGA
Transactions as of
10 Nov 2023
Net transactions value
+$291,503
Form type
4
Filing time
13 Nov 2023, 15:25:06 UTC
Previous filing
13 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGA Common Stock Options Exercise $162,162 +1,376 +8.6% $117.85 17,464 10 Nov 2023 Direct
transaction RGA Common Stock Tax liability $98,912 -610 -3.5% $162.15 16,854 10 Nov 2023 Direct F1
transaction RGA Common Stock Options Exercise $34,715 +239 +1.4% $145.25 17,093 10 Nov 2023 Direct
transaction RGA Common Stock Tax liability $17,188 -106 -0.62% $162.15 16,987 10 Nov 2023 Direct F2
transaction RGA Common Stock Options Exercise $17,501 +116 +0.68% $150.87 17,103 10 Nov 2023 Direct
transaction RGA Common Stock Tax liability $8,432 -52 -0.3% $162.15 17,051 10 Nov 2023 Direct F3
transaction RGA Common Stock Options Exercise $48,515 +374 +2.2% $129.72 17,425 10 Nov 2023 Direct
transaction RGA Common Stock Tax liability $26,917 -166 -0.95% $162.15 17,259 10 Nov 2023 Direct F4
transaction RGA Common Stock Options Exercise $44,849 +421 +2.4% $106.53 17,680 10 Nov 2023 Direct
transaction RGA Common Stock Tax liability $30,322 -187 -1.1% $162.15 17,493 10 Nov 2023 Direct F5
transaction RGA Common Stock Options Exercise $186,935 +1,449 +8.3% $129.01 18,942 10 Nov 2023 Direct
transaction RGA Common Stock Tax liability $21,404 -132 -0.7% $162.15 18,810 10 Nov 2023 Direct F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGA Stock Appreciation Right (right to purchase) 2020 Options Exercise $0 -5,039 -75% $0.000000 1,680 10 Nov 2023 Common Stock 5,039 $117.85 Direct F7
transaction RGA Stock Appreciation Right (right to purchase) 2019 Options Exercise $0 -2,294 -100% $0.000000* 0 10 Nov 2023 Common Stock 2,294 $145.25 Direct F7
transaction RGA Stock Appreciation Right (right to purchase) 2018 Options Exercise $0 -1,676 -100% $0.000000* 0 10 Nov 2023 Common Stock 1,676 $150.87 Direct F7
transaction RGA Stock Appreciation Right (right to purchase) 2017 Options Exercise $0 -1,873 -100% $0.000000* 0 10 Nov 2023 Common Stock 1,873 $129.72 Direct F7
transaction RGA Stock Appreciation Right (right to purchase) 2022 Options Exercise $0 -1,227 -25% $0.000000 3,683 10 Nov 2023 Common Stock 1,227 $106.53 Direct F7
transaction RGA Stock Appreciation Right (right to purchase) 2021 Options Exercise $0 -1,449 -50% $0.000000 1,450 10 Nov 2023 Common Stock 1,449 $129.01 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1. Represents (i) 3,663 shares sold to pay the exercise price the purchase of common stock, and (ii) 610 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 766 shares.
F2 1. Represents (i) 2,055 shares sold to pay the exercise price the purchase of common stock, and (ii) 106 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 133 shares.
F3 1. Represents (i) 1,560 shares sold to pay the exercise price the purchase of common stock, and (ii) 52 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 64 shares.
F4 1. Represents (i) 1,499 shares sold to pay the exercise price the purchase of common stock, and (ii) 166 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 208 shares.
F5 1. Represents (i) 806 shares sold to pay the exercise price the purchase of common stock, and (ii) 187 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 234 shares.
F6 1. Represents (i) 1,153 shares sold to pay the exercise price the purchase of common stock, and (ii) 132 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 164 shares.
F7 SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant.